Information about Pharmachol Belgium
My details
*
*
*
No warnings for this company
{{translate('company_activity_bron_' + bron)}}
NACE Description
{{activiteit.code}} {{activiteit.description}}

Pharmachol Belgium (SRL)

BE 0765.356.031

Industrielaan 3, 3730 Bilzen-Hoeselt
Company information
Status
Active
Enterprise number
BE0765.356.031
VAT liability
Yes
Established
18-03-2021
Last balance sheet year
2024
Company size
Small 0 FTE
Principal activity
Manufacture of basic pharmaceutical products
Health barometer
Credit limit
Detailpage

Are you looking for more information about this company?

  • Consult health at a glance

  • Choose quick insights or granular details

  • Get updates on important developments

Try for free Discover more

7-day free trial, no credit card required.

Financial data from Pharmachol Belgium
{{translate("download")}}

Publications in the Belgian Official Journal from Pharmachol Belgium

Date Publication
31-05-2024 Resignations - Appointments (NL)
21-10-2022 Resignations - Appointments (NL)
07-07-2021 Resignations - Appointments (NL)
22-03-2021 Rubric Constitution (New Juridical Person, Opening Branch, etc...) (NL)

Frequently asked questions

What is the VAT number of Pharmachol Belgium?
The VAT number of Pharmachol Belgium is BE0765356031.
When was Pharmachol Belgium founded?
Pharmachol Belgium was founded on 18-03-2021.
What is the address of Pharmachol Belgium?
The current registered office of Pharmachol Belgium is located at Industrielaan 3, 3730 Bilzen-Hoeselt.
When was the last time Pharmachol Belgium filed their annual financial statements?
The most recent financial statements of Pharmachol Belgium were filed on 13-12-2024. You can view them here.
How many employees does Pharmachol Belgium have?
There are currently no employees working at Pharmachol Belgium or no workforce information is available.
What is the annual turnover of Pharmachol Belgium?
At the time of its most recent financial statements, Pharmachol Belgium did not publish any turnover figures. Pharmachol Belgium reported a gross margin of €63,565.65.

Sources